12 May 2026 : Original article
A Retrospective Study of 518 Kidney Transplant Recipients to Evaluate the Association of Antiplatelet Therapy With Long-Term Cardiovascular Events and All-Cause Mortality
Gavin Christy BCEF 1, Andres Mata ABE 2, Zalan Shah B 1, Ananta M.H. Sriram B 1, Diana Pfeiffer B 1, Taylor R. Coffman
B 1, Madeline K. Johnson E 1, Sahita Gandra E 1, Krista L. Lentine ADEG 3, Mina M. Benjamin ADE 4*
DOI: 10.12659/AOT.951325
Ann Transplant 2026; 31:e951325
Figure 2 Kaplan-Meier survival curves for survival free of the composite outcome of all-cause mortality and major adverse cardiovascular events among 368 kidney transplant recipients without known cardiovascular disease, stratified by antiplatelet therapy status after transplantation. In the figure, “(No) Antiplatelet” – (no) antiplatelet therapy; “Logrank” represents the log-rank P value.